GFAP and Alzheimer disease: These previous findings propose that GFAP BDPs are likely present in TBI, ALS, SCI, Alexander disease, and Alzheimer’s disease-associated biofluids; here, we suggest the presence of these truncated forms in the TEV population and ADEV subpopulation of IS patients.